Inverness Medical Innovations is a leading provider of innovative diagnostic products for women's health and chronic disease management as well as leading the way in advanced technologies for both the consumer and professional diagnostic markets. We remain committed to advancing healthcare through a continual flow of innovative new products driven by our strategy of investing in R & D and intellectual property. By maintaining our own state-of-the-art manufacturing facilities, we produce high-quality, cutting edge products at the speed of life.
Through our internal R & D programmes, some strategic acquisitions and further planned acquisitions, our portfolio is rapidly growing and evolving. We currently have five key brands: Clearview, TestPack, Binax, Determine and Biostar ensuring that we are at the forefront of the global clinical rapid diagnostics market.
Other products are also available from Inverness Medical Innovations. This includes: Osteomark NTx and ACB (Albumin Cobalt Binding) test for Ischemia Modified Albumin.